Literature DB >> 17278997

The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease.

Giuseppe Di Fede1, Giorgio Giaccone, Lucia Limido, Michela Mangieri, Silvia Suardi, Gianfranco Puoti, Michela Morbin, Giulia Mazzoleni, Bernardino Ghetti, Fabrizio Tagliavini.   

Abstract

The 14-3-3 proteins are highly conserved, ubiquitous molecules involved in a variety of biologic events, such as transduction pathway modulation, cell cycle control, and apoptosis. Seven isoforms have been identified that are abundant in the brain, preferentially localized in neurons. Remarkable increases in 14-3-3 are seen in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease (CJD), and it has been found in pathologic inclusions of several neurodegenerative diseases. Moreover, the zeta isoform has been detected in prion protein (PrP) amyloid deposits of CJD patients. To further investigate the cerebral distribution of 14-3-3 in prion-related encephalopathies, we carried out an immunohistochemical and biochemical analysis of brain tissue from patients with Gerstmann-Sträussler-Scheinker disease (GSS) and sporadic, familial and acquired forms of CJD, using specific antibodies against the seven 14-3-3 isoforms. The study showed a strong immunoreactivity of PrP amyloid plaques of GSS patients for the 14-3-3 epsilon isoform, but not for the other isoforms. The epsilon isoform of 14-3-3 was not found in PrP deposits of CJD. These results indicate that the epsilon isoform of 14-3-3 is a component of PrP amyloid deposits of GSS and suggest that this is the sole 14-3-3 isoform specifically involved in the neuropathologic changes associated with this disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17278997     DOI: 10.1097/nen.0b013e3180302060

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

Review 1.  Interactions of prion protein with intracellular proteins: so many partners and no consequences?

Authors:  Krzysztof Nieznanski
Journal:  Cell Mol Neurobiol       Date:  2009-12-30       Impact factor: 5.046

2.  Novel alternative splicing isoform biomarkers identification from high-throughput plasma proteomics profiling of breast cancer.

Authors:  Fan Zhang; Mu Wang; Tran Michael; Renee Drabier
Journal:  BMC Syst Biol       Date:  2013-12-09

3.  Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells.

Authors:  Elina M Sutinen; Minna A Korolainen; Jukka Häyrinen; Irina Alafuzoff; Steven Petratos; Antero Salminen; Hilkka Soininen; Tuula Pirttilä; Johanna O Ojala
Journal:  Front Cell Neurosci       Date:  2014-08-07       Impact factor: 5.505

Review 4.  Translational Research in Alzheimer's and Prion Diseases.

Authors:  Giuseppe Di Fede; Giorgio Giaccone; Mario Salmona; Fabrizio Tagliavini
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 5.  The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease.

Authors:  Johanna O Ojala; Elina M Sutinen
Journal:  J Clin Med       Date:  2017-05-21       Impact factor: 4.241

Review 6.  Cellular Prion Protein (PrPc): Putative Interacting Partners and Consequences of the Interaction.

Authors:  Hajar Miranzadeh Mahabadi; Changiz Taghibiglou
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

7.  Agrypnia excitata and obstructive apnea in a patient with fatal familial insomnia from China: A case report.

Authors:  Congcong Sun; Wen Xia; Ying Liu; Guoyong Jia; Cuilan Wang; Chuanzhu Yan; Yi Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.